BioStem Technologies Inc. to Present at The MicroCap Conference on October 1st and 2nd in New York City at the Essex House
September 19, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Sept. 19, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
Nesvik Pharmaceuticals, Inc., a Subsidiary of BioStem Technologies, Inc., Announces Engagement of The Gnomon Group for Pre-Investigational New Drug Application Strategy
September 17, 2018 10:43 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Sept. 17, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...
Nesvik Pharmaceuticals, Inc., Receives Updated U.S. FDA Establishment Registration in Light of New Product Development
August 28, 2018 10:10 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals, Inc., a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), focused on...
BioStem Technologies, Inc. Completes 2016, 2017 Audit of Financial Statements
August 17, 2018 09:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL., Aug. 17, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM), a global life sciences corporation, providing innovative technologies with a concentration in...
BioStem Technologies, Inc. Engages Maxim Group LLC For Strategic Advisory Services
August 15, 2018 09:00 ET
|
BioStem Technologies, Inc.
Fort Lauderdale, FL, Aug. 15, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), (the “Company” or “BioStem Technologies”) a global life sciences corporation, providing innovative...
BioStem Technologies, Inc. (BSEM) Launches New Subsidiary to Engage in the Processing and Supply of Regenerative Tissue Products
August 09, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), BioStem Technologies, Inc. is a global life sciences corporation,...
BioStem Technologies Inc. Launches Expanded Shareholder Communications Initiative
August 08, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 08, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies (BSEM) Subsidiary Nesvik Pharmaceuticals Announces the Completion of An Asset Purchase of Multiple New Drug Compounds and Launches Joint Development Venture with CCM Pharma Solutions
July 19, 2018 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, July 19, 2018 (GLOBE NEWSWIRE) -- Nesvik Pharmaceuticals (f/k/a BioStem Pharmaceuticals), a subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”),...
BioStem Technologies Inc. Announces Issuance of Drug Enforcement Administration Registration for Qualified Pharma Ingredients
June 18, 2018 17:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 18, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies...
BioStem Technologies Inc. Enters Into Consulting and Advisory Agreement with Dr. Irmgard Huber
April 04, 2018 10:28 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, April 04, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with...